SCHEMBL12301955

SCHEMBL12301955

COc1cccc(OC)c1-c1ccc2c(c1)sc(C=C1C=CN(Cc3ccc(CN4CCN(C)CC4)cc3)c3ccccc31)[n+]2C

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ DRD4 P21917 3/20 0.37
▸ DRD2 P14416 3/20 0.37
▸ DRD3 P35462 2/20 0.37
▸ HRH2 P25021 1/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.37
▸ HTR7 P34969 8/20 0.36
▸ TGFBR1 P36897 1/20 0.36
▸ ACVR1 Q04771 1/20 0.36
▸ MAPK1 P28482 1/20 0.34
▸ UTS2R Q9UKP6 1/20 0.34
▸ HTR1A P08908 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR6 P50406 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ CHKA P35790 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.32
▸ ALK Q9UM73 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12301956 0.92 PDE4B (0.38) DRD4DRD2DRD3HRH2HTR7
SCHEMBL12302017 0.91 TNKS (0.37) CHKA
SCHEMBL12301969 0.90 HTR7 (0.32) DRD4HTR7HTR1A
SCHEMBL12301976 0.89 — —
SCHEMBL12301982 0.89 KDM4E (0.31) ALDH1A1
SCHEMBL12301954 0.89 — —
SCHEMBL12301965 0.87 HTR7 (0.35) DRD4DRD2DRD3HRH2HTR7
SCHEMBL18634247 0.87 HTR7 (0.35) HTR7HTR1AHTR2AHTR6
SCHEMBL12301967 0.87 — —
SCHEMBL12301963 0.87 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1885718-B1 FLUORESCENT CHEMICAL COMPOUNDS HAVING HIGH SELECTIVITY FOR DOUBLE STRANDED DNA, AND METHODS FOR THEIR USE LIFE TECHNOLOGIES CORP (US) 2017-03-15 — — EP disclosed
US-9366676-B2 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use Life Technologies Corporation (US) 2016-06-14 — — US disclosed
US-20150316558-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use MOLECULAR PROBES, INC. 2015-11-05 — — US disclosed
US-9115397-B2 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use Life Technologies Corporation (US) 2015-08-25 — — US disclosed
US-20150004597-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use LIFE TECHNOLOGIES CORP (US) 2015-01-01 — — US disclosed
US-8865904-B2 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use Life Technologies Corporation (US) 2014-10-21 — — US disclosed
US-20130224735-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use Life Technologies Corporation (US) 2013-08-29 — — US disclosed
US-20120288855-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use Life Technologies Corporation (US) 2012-11-15 — — US disclosed
US-20110217699-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use Life Technologies Corporation (US) 2011-09-08 — — US disclosed
US-7943777-B2 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use Life Technologies Corporation (US) 2011-05-17 — — US disclosed
US-20100143917-A1 FLUORESCENT CHEMICAL COMPOUNDS HAVING HIGH SELECTIVITY FOR DOUBLE STRANDED DNA, AND METHODS FOR THEIR USE Life Technologies Corporation (US) 2010-06-10 — — US disclosed
US-7598390-B2 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use Life Technologies Corporation (US) 2009-10-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110217699-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use POLRMT, DNA2, NSUN2 DRD4 1306/4885DRD2 1974/4885DRD3 2147/4885
US-20120288855-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use POLRMT, DNA2, NSUN2 DRD4 1306/4885DRD2 1974/4885DRD3 2147/4885
US-20100143917-A1 FLUORESCENT CHEMICAL COMPOUNDS HAVING HIGH SELECTIVITY FOR DOUBLE STRANDED DNA, AND METHODS FOR THEIR USE POLRMT, DNA2, NSUN2 DRD4 1306/4885DRD2 1974/4885DRD3 2147/4885
US-20150316558-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use POLRMT, DNA2, NSUN2 DRD4 1306/4885DRD2 1974/4885DRD3 2147/4885
US-20150004597-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use POLRMT, DNA2, NSUN2 DRD4 1306/4885DRD2 1974/4885DRD3 2147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback